Orrick Herrington & Sutcliffe LLP represented Kineta on the matter. Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here